[New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis]. / Neue Therapiemöglichkeiten beim metastasierten HER2-low-Mammakarzinom : Konsequenzen für die histopathologische Diagnostik.
Pathologie (Heidelb)
; 43(6): 457-466, 2022 Nov.
Article
in De
| MEDLINE
| ID: mdl-36227345
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Female
/
Humans
Language:
De
Journal:
Pathologie (Heidelb)
Year:
2022
Document type:
Article